Your browser doesn't support javascript.
loading
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study.
Welker, James; Pulido, Juan D; Catanzaro, Andrew T; Malvestutto, Carlos D; Li, Zihai; Cohen, Jonathan B; Whitman, Eric D; Byrne, Dana; Giddings, Olivia K; Lake, Jordan E; Chua, Joel V; Li, Ella; Chen, Jian; Zhou, Xiang; He, Kun; Gates, Davis; Kaur, Amarjot; Chen, Jamie; Chou, Hung-Yen; Devenport, Martin; Touomou, Raymond; Kottilil, Shyamasundaran; Liu, Yang; Zheng, Pan.
Affiliation
  • Welker J; Anne Arundel Research Institute, Annapolis, MD, USA.
  • Pulido JD; Baptist Medical Center, Jacksonville, FL, USA.
  • Catanzaro AT; Adventist HealthCare, Gaithersburg, MD, USA.
  • Malvestutto CD; Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH USA.
  • Li Z; Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH USA; Pelotonia Institute for Immuno-Oncology, The Ohio State University Wexner Medical Center, Columbus, OH USA.
  • Cohen JB; Adventist HealthCare, Gaithersburg, MD, USA.
  • Whitman ED; Atlantic Health System, Morristown, NJ, USA.
  • Byrne D; Division of Infectious Diseases, Department of Medicine, Cooper Medical School of Rowan University, Cooper University Healthcare, Camden, NJ, USA.
  • Giddings OK; University Hospitals, Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
  • Lake JE; Department of Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Chua JV; Institute of Human Virology, Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Li E; Edetek, Princeton, NJ, USA.
  • Chen J; Edetek, Princeton, NJ, USA.
  • Zhou X; Edetek, Princeton, NJ, USA.
  • He K; R&G US, North Potomac, MD, USA.
  • Gates D; Merck & Co, Kenilworth, NJ, USA.
  • Kaur A; Merck & Co, Kenilworth, NJ, USA.
  • Chen J; Edetek, Princeton, NJ, USA; ClinSmart, Newtown, PA, USA.
  • Chou HY; OncoImmune, Rockville, MD, USA.
  • Devenport M; OncoImmune, Rockville, MD, USA.
  • Touomou R; OncoImmune, Rockville, MD, USA.
  • Kottilil S; Institute of Human Virology, Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Liu Y; OncoImmune, Rockville, MD, USA; Division of Immunotherapy, Institute of Human Virology, UM Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Zheng P; OncoImmune, Rockville, MD, USA; Division of Immunotherapy, Institute of Human Virology, UM Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address:
Lancet Infect Dis ; 22(5): 611-621, 2022 05.
Article in En | MEDLINE | ID: mdl-35286843
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Adolescent / Adult / Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Adolescent / Adult / Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Type: Article Affiliation country: United States